Lesson plan

3C-TFE

3C-TFE, also known as 4-(2,2,2-trifluoroethoxy)-3,5-dimethoxyamphetamine or as α-methyltrifluoroescaline (3C-trifluoroescaline), is a psychedelic drug of the phenethylamine, amphetamine, and 3C families related to 3,4,5-trimethoxyamphetamine (TMA; 3C-M). It is a trifluorinated derivative of 3C-E. The drug's dose is 30 mg and its duration is approximately 15 hours. It shows weak but significant affinity for the serotonin 5-HT 2A and 5-HT 2C receptors (K i = 1,825 nM and 1,659 nM, respectively). 3C-TFE was first described in the scientific literature by Daniel Trachsel in 2002. The pharmacology of a number of 3C drugs was studied in 2021, but 3C-TFE was not one of the included compounds. It is a controlled substance in Canada as an analogue of amphetamine.

Back to article

Article summary

3C-TFE, also known as 4-(2,2,2-trifluoroethoxy)-3,5-dimethoxyamphetamine or as α-methyltrifluoroescaline (3C-trifluoroescaline), is a psychedelic drug of the phenethylamine, amphetamine, and 3C families related to 3,4,5-trimethoxyamphetamine (TMA; 3C-M). It is a trifluorinated derivative of 3C-E. The drug's dose is 30 mg and its duration is approximately 15 hours. It shows weak but significant affinity for the serotonin 5-HT 2A and 5-HT 2C receptors (K i = 1,825 nM and 1,659 nM, respectively). 3C-TFE was first described in the scientific literature by Daniel Trachsel in 2002. The pharmacology of a number of 3C drugs was studied in 2021, but 3C-TFE was not one of the included compounds. It is a controlled substance in Canada as an analogue of amphetamine.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.